• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - Authors' reply.

作者信息

Bowman Simon J, Dorner Thomas, Mariette Xavier, Luo Wen-Lin, Hueber Wolfgang

机构信息

Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK; Institute of Inflammation and Ageing, College of Medical and Dental Sciences and National Institute for Health Research Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK; Rheumatology Department, Milton Keynes University Hospital, Milton Keynes, UK.

Department of Medicine, Rheumatology and Clinical Immunology, Charité Universitätsmedizin and Deutsches Rheumaforschungszentrum, Berlin, Germany.

出版信息

Lancet. 2022 Sep 10;400(10355):808-809. doi: 10.1016/S0140-6736(22)01538-0.

DOI:10.1016/S0140-6736(22)01538-0
PMID:36088946
Abstract
摘要

相似文献

1
Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - Authors' reply.伊那鲁单抗治疗干燥综合征：我们能从狼疮试验中学到什么？——作者回复
Lancet. 2022 Sep 10;400(10355):808-809. doi: 10.1016/S0140-6736(22)01538-0.
2
Ianalumab in Sjögren's syndrome: what can we learn from lupus trials?伊那鲁单抗治疗干燥综合征：我们能从狼疮试验中学到什么？
Lancet. 2022 Sep 10;400(10355):807-808. doi: 10.1016/S0140-6736(22)01536-7.
3
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.皮下注射伊纳鲁单抗（VAY736）治疗原发性干燥综合征患者的安全性和有效性：一项随机、双盲、安慰剂对照的2b期剂量探索试验。
Lancet. 2022 Jan 8;399(10320):161-171. doi: 10.1016/S0140-6736(21)02251-0. Epub 2021 Nov 30.
4
Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.靶向 B 细胞 BAFF 受体阻断与增强的抗体依赖性细胞细胞毒性联用治疗原发性干燥综合征的 ian alumab（VAY736）。
Ann Rheum Dis. 2019 May;78(5):641-647. doi: 10.1136/annrheumdis-2018-214720. Epub 2019 Mar 2.
5
Stratifying primary Sjögren's syndrome: killers in the balance?原发性干燥综合征的分层：平衡中的致命因素？
Arthritis Res Ther. 2015 Dec 7;17:351. doi: 10.1186/s13075-015-0878-9.
6
Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis.生物制剂治疗干燥综合征、系统性红斑狼疮和狼疮性肾炎。
Curr Opin Rheumatol. 2020 Nov;32(6):609-616. doi: 10.1097/BOR.0000000000000754.
7
Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.用阿达木单抗成功治疗与克罗恩病相关的干燥综合征。
J Crohns Colitis. 2012 Mar;6(2):263. doi: 10.1016/j.crohns.2011.11.022. Epub 2011 Dec 21.
8
Obinutuzumab in patients with Sjogren's disease immunised against rituximab.奥妥珠单抗用于对利妥昔单抗免疫的干燥综合征患者。
Ann Rheum Dis. 2024 Feb 15;83(3):407-408. doi: 10.1136/ard-2023-224999.
9
[Sjögren's syndrome: from diagnosis to treatment].[干燥综合征：从诊断到治疗]
Rev Med Suisse. 2021 Mar 10;17(729):477-480.
10
Ianalumab (VAY736) in primary Sjögren's syndrome: assessing disease activity using multi-modal ultrasound.依那西普单抗（VAY736）治疗原发性干燥综合征：多模态超声评估疾病活动度。
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):228-236. Epub 2020 Oct 23.